Spravato, MAT, defensible notes, AriaMD setup, PHQ-9 and GAD-7. Written by clinicians on the team.
A five-day checklist: what to correct, what to template, and the settings that stop the same edit from repeating.
Open guideHow to chart a polypharmacy, partial-response med-management visit: interval history, regimen list, assessment reasoning, and plan.
REMS-aware Spravato documentation: pre-session checks, vitals timepoints, observation, discharge criteria, and a sample template.
What 2026 MAT notes need for buprenorphine, methadone, and naltrexone: intake fields, per-visit items, UDS, and 42 CFR Part 2 handling.
How to edit an AI draft so it does not read as templated: prune filler, vary phrasing, own the assessment, and attest on sign-off.
When to give the C-SSRS, how to score and chart it, and assessment language that holds up if a visit becomes a sentinel event.
When to give PHQ-9 and GAD-7, how to score and trend them, and how to keep scores structured for MBC reporting.
What a psychiatric timeline should hold (scales, meds, diagnoses, session context) and how to add one without replacing the EHR.
Medical necessity is the right signal, not a long note. How to chart S, O, A, and P so a reviewer can follow the visit.
Review E/M codes 99213-99215, add-on codes 90833, 90836, and 90838, and standalone codes 90834 and 90837.
How to edit an AI draft so it does not read as templated: prune filler, vary phrasing, own the assessment, and attest on sign-off.
When to give the C-SSRS, how to score and chart it, and assessment language that holds up if a visit becomes a sentinel event.
When to give PHQ-9 and GAD-7, how to score and trend them, and how to keep scores structured for MBC reporting.
What a psychiatric timeline should hold (scales, meds, diagnoses, session context) and how to add one without replacing the EHR.
Medical necessity is the right signal, not a long note. How to chart S, O, A, and P so a reviewer can follow the visit.
How to chart a polypharmacy, partial-response med-management visit: interval history, regimen list, assessment reasoning, and plan.
REMS-aware Spravato documentation: pre-session checks, vitals timepoints, observation, discharge criteria, and a sample template.
What 2026 MAT notes need for buprenorphine, methadone, and naltrexone: intake fields, per-visit items, UDS, and 42 CFR Part 2 handling.
How to edit an AI draft so it does not read as templated: prune filler, vary phrasing, own the assessment, and attest on sign-off.
When to give the C-SSRS, how to score and chart it, and assessment language that holds up if a visit becomes a sentinel event.
When to give PHQ-9 and GAD-7, how to score and trend them, and how to keep scores structured for MBC reporting.
What a psychiatric timeline should hold (scales, meds, diagnoses, session context) and how to add one without replacing the EHR.
Medical necessity is the right signal, not a long note. How to chart S, O, A, and P so a reviewer can follow the visit.
Review E/M codes 99213-99215, add-on codes 90833, 90836, and 90838, and standalone codes 90834 and 90837.
A five-day plan for a small group: workspace setup, provider invites, templates, automations, and the week-one metrics that predict adoption.
What a psychiatric timeline should hold (scales, meds, diagnoses, session context) and how to add one without replacing the EHR.
Review E/M codes 99213-99215, add-on codes 90833, 90836, and 90838, and standalone codes 90834 and 90837.
Build a Nextvisit intake template: editor path, variable tokens, required sections, and when to split into a second template.
What 42 CFR Part 2 requires for SUD records: who it covers, consent, segregation, disclosure logs, and how it changes the workspace.
What a psychiatry AI scribe has to capture: DSM-5 templates, live notes, HIPAA handling, EHR export, and audit-ready outcomes.
Evaluate psychiatry AI scribes for specialty templates, risk language, and session-to-session context.
If there's a workflow we haven't covered, send a note. The team writes guides for the questions practices ask us in onboarding, not the ones we guess at.